Skip to content

Clinical trials

Hyperphosphatemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Clear all

163 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20056
20069
200711
20087
200915
201015
20116
20129
201310
20147
20155
20167
20178
20186
201910
20208
20215
20224
20238
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed117
Unknown status19
Terminated14
Recruiting7
Withdrawn3
Suspended1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer10
Tanabe Pharma Corporation10
Astellas Pharma Inc8
Kyowa Kirin Co., Ltd.7
Ardelyx6
Genzyme, a Sanofi Company6
Keryx Biopharmaceuticals6
Kissei Pharmaceutical Co., Ltd.5
Ineos Healthcare Limited4
Shire4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia163
Renal Insufficiency, Chronic57
Kidney Failure, Chronic37
Renal Insufficiency18
Kidney Diseases10
Chronic Kidney Disease-Mineral and Bone Disorder6
Hyperparathyroidism, Secondary4
Anemia, Iron-Deficiency3
Cardiovascular Diseases3
Hypercalcemia3

Trials

Showing 1 to 25 of 163. Each trial links to its page on Pharma Observatory.

63 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.